VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10004882 | HBV | ENSG00000110887.8 | protein_coding | DAO | No | No | 1610 | A0A024RBI1 P14920 |
TVIS30081291 | HIV | ENSG00000110887.8 | protein_coding | DAO | No | No | 1610 | A0A024RBI1 P14920 |
TVIS20050653 | HPV | ENSG00000110887.8 | protein_coding | DAO | No | No | 1610 | A0A024RBI1 P14920 |
TVIS44013560 | HTLV-1 | ENSG00000110887.8 | protein_coding | DAO | No | No | 1610 | A0A024RBI1 P14920 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | DAO |
---|---|
DrugBank ID | DB02838 |
Drug Name | 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate |
Target ID | BE0004141 |
UniProt ID | P14920 |
Regulation Type | |
PubMed IDs | 17139284; 17016423; 10592235 |
Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
Groups | Experimental |
Direct Classification | Pyrrolines |
SMILES | [O-]C(=O)C1=[NH+]CCC1 |
Pathways | Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Ornithine Aminotransferase Deficiency (OAT Deficiency); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Hyperprolinemia Type I; Hyperprolinemia Type II; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Arginine and Proline Metabolism; D-Arginine and D-Ornithine Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Prolinemia Type II; L-Arginine:Glycine Amidinotransferase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency |
PharmGKB | |
ChEMBL | CHEMBL18591 |